When Aβ is injected into the peritoneum of AD mouse models, it activates the hepatic Jak2/STAT3/SOCS-1 pathway, resulting in elevated fasting glucose and impaired insulin tolerance and hepatic insulin signaling [189]. This evidence concerns the gene JAK2 and Alzheimer disease.